Walgreen (WAG) posted earnings of $683 million, or seventy eight cents per diluted share.
Compared with the prior year's quarter, the mild cough/cold and flu season impacted net earnings per diluted share by three cents, while the effect of no longer being part of the Express Scripts (NASDAQ:ESRX) pharmacy provider network as of Jan. 1, 2012, impacted results by seven cents per diluted share.
Shares of Walgreen are trading higher in early morning trading.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.